Cargando…

The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation

Reproductive history and exogenous hormonal exposures are acknowledged risk factors for breast cancer in the general population. In women at increased breast cancer risk for genetic predisposition or positive family history, data regarding these risk factors are limited or conflicting, and recommend...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toss, Angela, Grandi, Giovanni, Cagnacci, Angelo, Marcheselli, Luigi, Pavesi, Silvia, De Matteis, Elisabetta, Razzaboni, Elisabetta, Tomasello, Chiara, Cascinu, Stefano, Cortesi, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354721/ https://www.ncbi.nlm.nih.gov/pubmed/27880720 http://dx.doi.org/10.18632/oncotarget.13423

Ejemplares similares

Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes
por: Toss, Angela, et al.
Publicado: (2015)

Hereditary Pancreatic Cancer: A Retrospective Single-Center Study of 5143 Italian Families with History of BRCA-Related Malignancies
por: Toss, Angela, et al.
Publicado: (2019)

The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life
por: Grandi, Giovanni, et al.
Publicado: (2015)

BRCA Detection Rate in an Italian Cohort of Luminal Early-Onset and Triple-Negative Breast Cancer Patients without Family History: When Biology Overcomes Genealogy
por: Toss, Angela, et al.
Publicado: (2020)

The Prognostic and Predictive Role of Somatic BRCA Mutations in Ovarian Cancer: Results from a Multicenter Cohort Study
por: Toss, Angela, et al.
Publicado: (2021)

Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCA
por: Piombino, Claudia, et al.
Publicado: (2020)

BRCA mutation rate and characteristics of prostate tumor in breast and ovarian cancer families: analysis of 6,591 Italian pedigrees
por: Cortesi, Laura, et al.
Publicado: (2021)

BRCA mutation carriers’ perceptions on postmenopausal hormone therapy: An Italian study
por: Grandi, Giovanni, et al.
Publicado: (2021)

Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat?
por: Toss, Angela, et al.
Publicado: (2017)

Germline Mutations in Other Homologous Recombination Repair-Related Genes Than BRCA1/2: Predictive or Prognostic Factors?
por: Cortesi, Laura, et al.
Publicado: (2021)

Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers
por: Toss, Angela, et al.
Publicado: (2021)

Ovarian Cancer: Can Proteomics Give New Insights for Therapy and Diagnosis?
por: Toss, Angela, et al.
Publicado: (2013)

Male mammary myofibroblastoma: Two case reports and brief review of literature
por: Venturelli, Marta, et al.
Publicado: (2020)

Lifestyle Intervention on Body Weight and Physical Activity in Patients with Breast Cancer Can Reduce the Risk of Death in Obese Women: The EMILI Study
por: Cortesi, Laura, et al.
Publicado: (2020)

A phase II study of pembrolizumab plus carboplatin in BRCA-related metastatic breast cancer (PEMBRACA)
por: Cortesi, L., et al.
Publicado: (2023)

Development and Validation of an Italian Adaptation of the Psychosocial Aspects of Hereditary Cancer Questionnaire
por: Franiuk, Marzena, et al.
Publicado: (2021)

The Controversial History of Hormone Replacement Therapy
por: Cagnacci, Angelo, et al.
Publicado: (2019)

Breast ultrasound in high-risk women
por: Cortesi, Laura, et al.
Publicado: (2019)

Constitutional Mosaicism: A Critical Issue in the Definition of BRCA-Inherited Cancer Risk
por: Tenedini, Elena, et al.
Publicado: (2022)

BRCA1 and BRCA2 mutations in central and southern Italian patients
por: Ottini, Laura, et al.
Publicado: (2000)

Risk of Second Primary Malignancy in Breast Cancer Survivors: A Nested Population-Based Case-Control Study
por: Marcheselli, Raffaella, et al.
Publicado: (2015)

Risk-Reducing Breast and Gynecological Surgery for BRCA Mutation Carriers: A Narrative Review
por: Bertozzi, Serena, et al.
Publicado: (2023)

Natural history of NASH
por: Armandi, Angelo, et al.
Publicado: (2021)

Spectrum of Germline Pathogenic Variants in BRCA1/2 Genes in the Apulian Southern Italy Population: Geographic Distribution and Evidence for Targeted Genetic Testing
por: Patruno, Margherita, et al.
Publicado: (2021)

Characterization of three alternative transcripts of the BRCA1 gene in patients with breast cancer and a family history of breast and/or ovarian cancer who tested negative for pathogenic mutations
por: GAMBINO, GAETANA, et al.
Publicado: (2015)

Assisted Reproductive Technology and Breech Delivery: A Nationwide Cohort Study in Singleton Pregnancies
por: Londero, Ambrogio P., et al.
Publicado: (2023)

Hereditary Susceptibility to Breast Cancer: Significance of Age of Onset in Family History and Contribution of BRCA1 and BRCA2
por: Frank, Thomas S., et al.
Publicado: (1999)

Association of polymorphisms with a family history of cancer and the presence of germline mutations in the BRCA1/BRCA2 genes
por: Fernandes, Gabriela C., et al.
Publicado: (2016)

Cancer Spectrum, Family History of Cancer and Overall Survival in Men with Germline BRCA1 or BRCA2 Mutations
por: Reichl, Florian, et al.
Publicado: (2021)

Familial history and prevalence of BRCA1, BRCA2 and TP53 pathogenic variants in HBOC Brazilian patients from a public healthcare service
por: Matta, Bruna Palma, et al.
Publicado: (2022)

Next-generation sequencing of BRCA1 and BRCA2 genes in Moroccan prostate cancer patients with positive family history
por: Salmi, Fatiha, et al.
Publicado: (2021)

Tumor BRCA testing in ovarian cancer and EQA scheme: our experience of a critical evaluation
por: De Paolis, Elisa, et al.
Publicado: (2021)

BRCA1 and BRCA2 Gene Mutations in Breast/Ovarian Cancer Patients from Central and Southern Italy
por: Ottini, Laura, et al.
Publicado: (1999)

BRCA1 and BRCA2 Germline Mutations in Malaysian Women with Early-Onset Breast Cancer without a Family History
por: Toh, Gaik Theng, et al.
Publicado: (2008)

A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history
por: Gómez García, Encarna B, et al.
Publicado: (2009)

Prevalence of menstrual pain in young women: what is dysmenorrhea?
por: Grandi, Giovanni, et al.
Publicado: (2012)

Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: analysis of prognostic factors and survival
por: Biglia, Nicoletta, et al.
Publicado: (2016)

Molecular characterization of BRCA1 and BRCA2 genes in breast cancer patients under 40 years-old or with familiar cancer history
por: Millan, Silvia Vidal, et al.
Publicado: (2007)

Obesity in Postmenopausal Breast Cancer Patients: It Is Time to Improve Actions for a Healthier Lifestyle. The Results of a Comparison Between Two Italian Regions With Different “Presumed” Lifestyles
por: Cortesi, Laura, et al.
Publicado: (2021)

Characterization of BRCA1/2 mutations in patients with family history of breast cancer in Armenia
por: Atshemyan, Sofi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_or5823ma7sb71q57idelvu99dk